"Teicoplanin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glycopeptide antibiotic complex from Actinoplanes teichomyceticus active against gram-positive bacteria. It consists of five major components each with a different fatty acid moiety.
| Descriptor ID |
D017334
|
| MeSH Number(s) |
D09.400.420.900 D12.644.233.900
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Teicoplanin".
Below are MeSH descriptors whose meaning is more specific than "Teicoplanin".
This graph shows the total number of publications written about "Teicoplanin" by people in this website by year, and whether "Teicoplanin" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Teicoplanin" by people in Profiles.
-
Newer glycopeptide antibiotics for treatment of complicated skin and soft tissue infections: systematic review, network meta-analysis and cost analysis. Clin Microbiol Infect. 2018 Apr; 24(4):361-368.
-
A spectrum of changes occurs in peptidoglycan composition of glycopeptide-intermediate clinical Staphylococcus aureus isolates. Antimicrob Agents Chemother. 2001 Jan; 45(1):280-7.
-
In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci. Antimicrob Agents Chemother. 1999 Aug; 43(8):2059-62.
-
Cloning of the Staphylococcus aureus ddh gene encoding NAD+-dependent D-lactate dehydrogenase and insertional inactivation in a glycopeptide-resistant isolate. J Bacteriol. 1997 Nov; 179(21):6756-63.
-
Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibility. J Infect Dis. 1992 Nov; 166(5):1066-72.
-
Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis. Antimicrob Agents Chemother. 1991 Apr; 35(4):696-700.
-
Treatment evaluation of experimental staphylococcal infections: comparison of beta-lactam, lipopeptide, and glycopeptide antimicrobial therapy. J Lab Clin Med. 1990 Nov; 116(5):697-706.
-
Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis. J Infect Dis. 1990 Jul; 162(1):103-8.